LENZ (lenz-tx.com) יחס שווי שוק לשווי בספרים

This chart of the market valuation of LENZ Therapeutics, Inc. (LENZ) on the GURU.Markets platform demonstrates the dynamics of a company creating a non-invasive method for correcting presbyopia. The business is based on the development of eye drops capable of replacing reading glasses, providing access to a massive segment of the elderly population. The current metric stands at 0.45, while pricing power will emerge following regulatory approval of the drug, as the company currently generates no revenue.

To minimize investment risks, it is critical to assess the real net asset value of LENZ Therapeutics, Inc. (LENZ), especially given its outsourcing model for clinical trials and manufacturing. This chart of market capitalization to book value demonstrates the market value premium over equity, allowing for the determination of the business's margin of safety and the probability of a deep price correction.